The Senior Director/Executive Director will work with Therapeutic Unit Head (TUH), HemOnc Senior Leadership team (SLT) and key internal and external stakeholders to lead and coordinate the growth of the cell and gene therapy segment of the TU whilst supporting operational excellence in the conduct of awarded trials. – Accountable for focused growth in cell gene therapy (CGT) to support expansion of PPD wallet share – Accountable for cell therapy TU strategy including growth plan, pipeline analy…

Source ⇲